MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, MRNA has $12,338M in assets. $3,688M in debts. $2,595M in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
329.34%
Quick Ratio
321.64%
Cash Ratio
130.60%
Debt to Asset Ratio
29.89%
Unit: Million (M) dollars
Assets Breakdown
    • Investments
    • Cash and cash equivalents
    • Investments, non-current
    • Right-of-use assets, operating l...
Liabilities Breakdown
    • Retained earnings
    • Accrued liabilities
    • Additional paid-in capital
    • Others

Balance Sheets
2025-12-31
2024-12-31
2023-12-31
2022-12-31
Cash and cash equivalents
2,595 1,927 2,907 3,205
Investments
3,204 5,098 5,697 6,697
Accounts receivable, net
184 358 892 1,385
Inventory
153 117 202 949
Prepaid expenses and other current assets
408 599 627 1,195
Total current assets
6,544 8,099 10,325 13,431
Investments, non-current
2,336 2,494 4,677 8,318
Property, plant and equipment, net
2,134 2,196 1,945 2,018
Right-of-use assets, operating leases
719 759 713 121
Deferred tax assets
--81 982
Other non-current assets
605 594 685 988
Total assets
12,338 14,142 18,426 25,858
Accounts payable
317 405 520 487
Accrued liabilities
1,386 1,427 1,798 2,101
Deferred revenue
99 153 568 2,038
Income taxes payable
--63 48
Other current liabilities
185 221 66 249
Total current liabilities
1,987 2,206 3,015 4,923
Deferred revenue, non-current
153 58 83 673
Operating lease liabilities, non-current
653 671 643 92
Financing lease liabilities, non-current
20 39 575 912
Long-term debt
590 ---
Other non-current liabilities
285 267 256 135
Total liabilities
3,688 3,241 4,572 6,735
Additional paid-in capital
1,382 866 371 1,173
Accumulated other comprehensive income (loss)
45 -10 -123 -370
Retained earnings
7,223 10,045 13,606 18,320
Total stockholders equity
8,650 10,901 13,854 19,123
Total liabilities and stockholders equity
12,338 14,142 18,426 25,858
Unit: Million (M) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Investments$3,204M (-37.15%↓ Y/Y)Cash and cashequivalents$2,595M (34.67%↑ Y/Y)Prepaid expenses andother current assets$408M (-31.89%↓ Y/Y)Accounts receivable, net$184M (-48.60%↓ Y/Y)Inventory$153M (30.77%↑ Y/Y)Total current assets$6,544M (-19.20%↓ Y/Y)Investments, non-current$2,336M (-6.34%↓ Y/Y)Property, plant andequipment, net$2,134M (-2.82%↓ Y/Y)Right-of-use assets,operating leases$719M (-5.27%↓ Y/Y)Other non-currentassets$605M (1.85%↑ Y/Y)Total assets$12,338M (-12.76%↓ Y/Y)Total liabilities andstockholders equity$12,338M (-12.76%↓ Y/Y)Total stockholdersequity$8,650M (-20.65%↓ Y/Y)Total liabilities$3,688M (13.79%↑ Y/Y)Retained earnings$7,223M (-28.09%↓ Y/Y)Additional paid-in capital$1,382M (59.58%↑ Y/Y)Accumulated othercomprehensive income (loss)$45M (550.00%↑ Y/Y)Total currentliabilities$1,987M (-9.93%↓ Y/Y)Operating leaseliabilities, non-current$653M (-2.68%↓ Y/Y)Long-term debt$590M Other non-currentliabilities$285M (6.74%↑ Y/Y)Deferred revenue,non-current$153M (163.79%↑ Y/Y)Financing leaseliabilities, non-current$20M (-48.72%↓ Y/Y)Accrued liabilities$1,386M (-2.87%↓ Y/Y)Accounts payable$317M (-21.73%↓ Y/Y)Other currentliabilities$185M (-16.29%↓ Y/Y)Deferred revenue$99M (-35.29%↓ Y/Y)

Master Final R&D Day 2021 Slides (09

Moderna, Inc. (MRNA)

Master Final R&D Day 2021 Slides (09

Moderna, Inc. (MRNA)